OTCQB is the venture marketplace for companies that are current in their reporting with a U.S. regulator, making it easy for investors to identify companies that are current in their reporting obligations.
Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient. Link to Patent: http://www.patentstorm.us/patents/7347841.html World's first US patented* technology to eliminate administration of incorrect medicinal substances by hypodermic needle.
Administering the right drug with the right dose to the right patient at the right time.
* Patent No. 7,347,841 B2 Granted on: March 25, 2008
400,000 preventable drug related injuries per year.
Up to 98,000 Americans die each year due to medical errors by healthcare professionals.